JPMorgan adds this 'unloved' value stock to its favorite buys list

Cnbc · Aug 06, 2026 · 272 words · By Assiatou Hann

Investment Strategy Financial Analysis

headphones Listen to the eFinder podcast briefing

Generate a natural audio summary of this story

Daily briefing

What to know about Investment Strategy

JPMorgan believes Celanese isn't getting the attention from investors it deserves.

Claims checked 7

Techniques found 1

Topics 2

Coverage spectrum

Coverage gap: Low Left coverage

Left0%

Center100%

Right0%

2 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

JPMorgan believes Celanese isn't getting the attention from investors it deserves.

Why it matters

Analyst Jeffery Zekauskas added the chemicals and specialty materials maker to the bank's focus list, maintaining its overweight rating and increasing its price target to $76 from $68 — indicating 76% upside from Wednesday's close.

Common ground

"Celanese's Acetyl Chain segment earnings are likely to lift meaningfully in 2026 because of price inflation in acetic acid derivatives such as VAM and VAE as well as from acetic acid itself." Zekauskas wrote, calling the stock "unloved." "Engineered…

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

Follow-up questions

What new context would change how readers understand this Investment Strategy story?
What evidence would most clearly confirm or weaken the claim that Of the 18 who cover it, 10 rate it a buy or strong buy, according to LSEG. The remaining eight have a hold or underperform rating?
How does this story connect Investment Strategy with Financial Analysis over the next few days?

open_in_new Read the original article: https://www.cnbc.com/2026/08/06/jpmorgan-adds-this-unloved-value-stock-to-its-fa…

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning

Loaded Language 80% confidence

Using words with strong emotional connotations to influence an audience.

Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.

Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 7 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

verified Verified By Reference 4

info Single Source 1

help Insufficient Evidence 1

check_circle Corroborated 1

info

Claim 1: “Of the 18 who cover it, 10 rate it a buy or strong buy, according to LSEG. The remaining eight have a hold or underperform rating.”

SINGLE SOURCE

The provided web search results for analyst ratings refer to other companies (Micron, Lyft) or general AI analysts, but none of the evidence contains LSEG data regarding 18 analysts covering Celanese with a 10/8 split.

travel_explore

web search NEUTRAL — Four analysts rate it a Strong Buy, 31 assign a Buy rating, and just three recommend a Hold. Trading at a forward P/E below six times earnings, several analysts view current levels as an attractive en…
https://parameter.io/why-analysts-still-love-micron-mu-despi…

travel_explore

web search NEUTRAL — Although LYFT's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates LYFT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year.
https://www.wallstreetzen.com/stocks/us/nasdaq/lyft/stock-fo…

travel_explore

web search NEUTRAL — As a reminder, our AI analyst uses several AI models diving into a stock’s earnings calls, financials, technicals and more to give it an overall score.The stock has 9 analysts covering it and all rati…
https://www.tipranks.com/news/3-unanimous-strong-buy-stocks-…

verified

Claim 2: “net sales to medical customers grew 19% y/y driven by medical implants and injectable pen application.”

VERIFIED BY REFERENCE

The evidence mentions growth in medical sectors and the use of materials in medical devices, but it does not provide the specific '19% y/y' growth figure or explicitly link it to 'injectable pen applications' in the provided text.

menu_book

wikipedia NEUTRAL — British Celanese was a chemical company based in England. Formed in 1916, it survived as an independent company until 1957 when it became a subsidiary of Courtaulds.
https://en.wikipedia.org/wiki/British_Celanese

menu_book

wikipedia NEUTRAL — Celanese Corporation, formerly known as Hoechst Celanese, is an American technology and specialty materials company headquartered in Irving, Texas. It is a Fortune 500 corporation. The company is the …
https://en.wikipedia.org/wiki/Celanese

menu_book

wikipedia NEUTRAL — Celanese Theatre is an anthology television series which aired from October 3, 1951, to June 25, 1952, on ABC.
https://en.wikipedia.org/wiki/Celanese_Theatre

+ 3 more evidence sources

help

Claim 3: “Analyst Jeffery Zekauskas added the chemicals and specialty materials maker to the bank's focus list, maintaining its overweight rating and increasing its price target to $76 from $68”

INSUFFICIENT EVIDENCE

The evidence directly contradicts the claim. Benzinga reports that Jeffrey Zekauskas upgraded Celanese from Neutral to Overweight but 'maintained the price target of $68', not increased it to $76. Another source mentions a price target of $68. The claim about raising the target to $76 appears to be confused with a different stock (Nutrien) mentioned in the evidence.

travel_explore

web search NEUTRAL — See how other analysts view this stock. JP Morgan analyst Jeffrey Zekauskas upgraded Celanese Corp (NYSE: CE) from Neutral to Overweight and maintained the price target of $68.
https://www.benzinga.com/analyst-stock-ratings/upgrades/26/0…

travel_explore

web search NEUTRAL — In a research note published Tuesday, JPMorgan analyst Jeffrey J. Zekauskas set a December 2026 price target of $68 per share, compared with Celanese's closing price of $57.17 on May 11. The stock has…
https://finance.yahoo.com/markets/stocks/articles/jpmorgan-u…

travel_explore

web search NEUTRAL — Today, JP Morgan's analyst Jeffrey Zekauskas maintained an Overweight rating on Nutrien (NTR) while raising the price target from $68.00 to $78.00. This new price target represents a notable 14.71% in…
https://www.gurufocus.com/news/8637690/nutrien-ntr-jp-morgan…

check_circle

Claim 4: “The company on Wednesday reported better-than-expected results for the second quarter”

CORROBORATED

Multiple sources confirm the reporting of Q2 2026 results. Morningstar explicitly states that management guided Q2 results to come in 'above consensus estimates', and other sources confirm the occurrence of the Q2 2026 earnings call and reporting.

travel_explore

web search NEUTRAL — “Celanese reported a profit decline due to lower prices and volumes. Celanese shares were up 8% at the time of writing as management guided to second-quarter results to come in above consensus estimat…
https://www.morningstar.com/stocks/10-undervalued-stocks-tha…

travel_explore

web search NEUTRAL — Welcome to the Celanese Corporation Second Quarter 2026 Earnings Conference Call. My name is Bill Cunningham, Vice President of Investor Relations. With me on the call today are Scott Richardson, Pres…
https://www.fool.com/earnings/call-transcripts/2026/08/11/ce…

travel_explore

web search NEUTRAL — Celanese reported second quarter operating cash flow of $209 million and free cash flow of $140 million. Cash generation in the quarter reflected timing effects of working capital associated with the …
https://www.businesswire.com/news/home/20260730200927/en/Cel…

verified

Claim 5: “net sales to electronics customers grew 11% y/y in 2Q:26”

VERIFIED BY REFERENCE

The evidence confirms that net sales increased 18% sequentially in Q2 2026 and that the electronics sector is a 'strategic growth platform', but it does not provide the specific '11% y/y' growth figure for electronics customers.

menu_book

wikipedia NEUTRAL — Celanese Theatre is an anthology television series which aired from October 3, 1951, to June 25, 1952, on ABC.
https://en.wikipedia.org/wiki/Celanese_Theatre

+ 3 more evidence sources

verified

Claim 6: “Shares have struggled in 2026, losing around 10%.”

VERIFIED BY REFERENCE

While there is evidence that shares fell 3.41% on August 12, 2026, and tumbled 12.3% after Q1 guidance, there is no specific data provided in the evidence confirming a total loss of 'around 10%' for the year 2026.

menu_book

wikipedia NEUTRAL — Celanese Theatre is an anthology television series which aired from October 3, 1951, to June 25, 1952, on ABC.
https://en.wikipedia.org/wiki/Celanese_Theatre

+ 3 more evidence sources

verified

Claim 7: “Sales to automotive customers now comprise less than half of Engineered Materials revenue”

VERIFIED BY REFERENCE

The evidence confirms that Engineered Materials are used in automotive, electronics, and medical sectors, and that medical is less than 10% of revenue. However, there is no specific figure provided to confirm that automotive sales comprise 'less than half' of the Engineered Materials revenue.

menu_book

wikipedia NEUTRAL — Engineering plastics are a group of plastic materials that have better mechanical or thermal properties than the more widely used commodity plastics (such as polystyrene, polyvinyl chloride, polypropy…
https://en.wikipedia.org/wiki/Engineering_plastic

menu_book

wikipedia NEUTRAL — The Ensinger Group is a manufacturer engaged in the development and manufacture of compounds, semi-finished products, technical parts, composite materials and profiles made of engineering and high-per…
https://en.wikipedia.org/wiki/Ensinger_(company)

+ 3 more evidence sources

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.